A number of firms have modified their ratings and price targets on shares of Alignment Healthcare (NASDAQ: ALHC) recently:
- 8/10/2022 – Alignment Healthcare had its price target raised by analysts at Morgan Stanley from $18.00 to $19.00. They now have an "overweight" rating on the stock.
- 8/8/2022 – Alignment Healthcare had its price target raised by analysts at Barclays PLC from $14.00 to $21.00. They now have an "overweight" rating on the stock.
- 8/8/2022 – Alignment Healthcare had its price target raised by analysts at UBS Group AG from $11.00 to $17.00. They now have a "neutral" rating on the stock.
- 8/8/2022 – Alignment Healthcare had its price target raised by analysts at The Goldman Sachs Group, Inc. from $14.00 to $21.00. They now have a "buy" rating on the stock.
- 8/5/2022 – Alignment Healthcare had its price target raised by analysts at Piper Sandler from $15.00 to $20.00. They now have an "overweight" rating on the stock.
Alignment Healthcare Stock Performance
NASDAQ:ALHC opened at $16.48 on Monday. The company has a current ratio of 2.74, a quick ratio of 2.74 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $3.09 billion, a P/E ratio of -20.10 and a beta of 2.05. The firm has a 50-day moving average price of $13.39 and a two-hundred day moving average price of $10.93. Alignment Healthcare, Inc. has a twelve month low of $6.14 and a twelve month high of $23.35.
Get Alignment Healthcare Inc alerts:Alignment Healthcare (NASDAQ:ALHC – Get Rating) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.20. Alignment Healthcare had a negative net margin of 11.20% and a negative return on equity of 47.96%. During the same period last year, the firm earned ($0.25) EPS. As a group, research analysts expect that Alignment Healthcare, Inc. will post -0.81 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, CEO John E. Kao sold 500,000 shares of the company's stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $15.95, for a total value of $7,975,000.00. Following the sale, the chief executive officer now directly owns 2,849,200 shares in the company, valued at $45,444,740. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO John E. Kao sold 25,752 shares of the firm's stock in a transaction that occurred on Wednesday, July 6th. The shares were sold at an average price of $13.04, for a total transaction of $335,806.08. Following the sale, the chief executive officer now owns 3,539,639 shares in the company, valued at $46,156,892.56. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO John E. Kao sold 500,000 shares of the business's stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $15.95, for a total value of $7,975,000.00. Following the completion of the transaction, the chief executive officer now owns 2,849,200 shares of the company's stock, valued at $45,444,740. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 772,667 shares of company stock valued at $11,625,395. Corporate insiders own 5.70% of the company's stock.Institutional Investors Weigh In On Alignment Healthcare
Hedge funds have recently made changes to their positions in the business. Nisa Investment Advisors LLC lifted its position in Alignment Healthcare by 26.8% during the second quarter. Nisa Investment Advisors LLC now owns 3,803 shares of the company's stock worth $43,000 after buying an additional 803 shares during the period. US Bancorp DE grew its holdings in shares of Alignment Healthcare by 15.8% during the 2nd quarter. US Bancorp DE now owns 6,704 shares of the company's stock worth $76,000 after purchasing an additional 914 shares during the period. Principal Financial Group Inc. increased its position in Alignment Healthcare by 7.7% during the 1st quarter. Principal Financial Group Inc. now owns 14,524 shares of the company's stock worth $163,000 after purchasing an additional 1,034 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Alignment Healthcare by 10.4% in the first quarter. Victory Capital Management Inc. now owns 11,124 shares of the company's stock valued at $107,000 after buying an additional 1,045 shares during the period. Finally, First Quadrant LLC CA purchased a new position in Alignment Healthcare in the first quarter valued at approximately $47,000. Institutional investors and hedge funds own 82.68% of the company's stock.
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.
Recommended Stories
- Get a free copy of the StockNews.com research report on Alignment Healthcare (ALHC)
- Here is a Simple 4 Stock Portfolio that Can Outperform the Market
- Is AMC Entertainment Pulling a Fast One on the APEs?
- Here's How the Inflation Reduction Act Energizes Power Stock
- MarketBeat: Week in Review 8/8 – 8/12
- 2 Important Retail Stock Battles to Watch
Receive News & Ratings for Alignment Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.